[Reduced clostridial protein content].
Blümel
Jörg
J
EUROTOX Registered Toxicologist Manager, Nonclinical Safety Testing, Merz Pharmaceuticals GmbH, Frankfurt.
D000818:Animals; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000138:chemical synthesis / Q000627:therapeutic use*; D020821:Dystonic Disorders / Q000188:drug therapy / Q000451:nursing*; D005858:Germany; D006801:Humans; D008970:Molecular Weight; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000138:chemical synthesis / Q000627:therapeutic use*; D013035:Spasm / Q000188:drug therapy / Q000451:nursing*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A